These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 31164625)
1. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer. Chen H; Liu Y; Jiang CJ; Chen YM; Li H; Liu QA Med Sci Monit; 2019 Jun; 25():4176-4185. PubMed ID: 31164625 [TBL] [Abstract][Full Text] [Related]
2. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling. Liu Z; Chen M; Xie LK; Liu T; Zou ZW; Li Y; Chen P; Peng X; Ma C; Zhang WJ; Li PD Aging (Albany NY); 2018 Oct; 10(10):2570-2584. PubMed ID: 30312171 [TBL] [Abstract][Full Text] [Related]
3. miR-19a targeting CLCA4 to regulate the proliferation, migration, and invasion of colorectal cancer cells. Li H; Huang B Eur J Histochem; 2022 Mar; 66(1):. PubMed ID: 35266369 [TBL] [Abstract][Full Text] [Related]
4. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
5. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405 [TBL] [Abstract][Full Text] [Related]
6. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685 [TBL] [Abstract][Full Text] [Related]
7. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657 [TBL] [Abstract][Full Text] [Related]
8. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway. Wang F; Ruan XJ; Zhang HY Tumori; 2015; 101(2):238-45. PubMed ID: 25908029 [TBL] [Abstract][Full Text] [Related]
9. CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway. Hou T; Zhou L; Wang L; Kazobinka G; Zhang X; Chen Z Oncotarget; 2017 Nov; 8(54):93001-93013. PubMed ID: 29190973 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
12. MOR promotes epithelial-mesenchymal transition and proliferation via PI3K/AKT signaling pathway in human colorectal cancer. Gao L; Yang L; He Y; Liu Y; Xu P; Zhang J; Dai S; Luo X; Sun Z Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 55(1):72-80. PubMed ID: 35983971 [TBL] [Abstract][Full Text] [Related]
13. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway. Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126 [TBL] [Abstract][Full Text] [Related]
14. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway. Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983 [TBL] [Abstract][Full Text] [Related]
15. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway. Cong K; Li CG; Wei YH; Zhang K; Xu HB Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352 [TBL] [Abstract][Full Text] [Related]
17. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling. Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761 [TBL] [Abstract][Full Text] [Related]
18. Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway. Chen XF; Liu PG; Sheng N; Li XS; Hu RK; Zhu LX; Feng P PLoS One; 2024; 19(9):e0308947. PubMed ID: 39331595 [TBL] [Abstract][Full Text] [Related]
19. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway. Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296 [TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]